Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

A study published in Immunity shows that antibody responses to SARS-CoV-2 infection and vaccination are long-lasting, with an initial decline followed by stabilization after seven to nine months, highlighting the effectiveness of mRNA vaccines and the importance of hybrid immunity.

25 Feb 2024

Omalizumab shows promise in preventing food allergy reactions in children, study finds

A drug can make life safer for children with food allergies by preventing dangerous allergic responses to small quantities of allergy-triggering foods, according to a new study led by scientists at the Stanford School of Medicine.

25 Feb 2024

Global health boost as new vaccine SKYTyphoid gains WHO prequalification

SK bioscience and the International Vaccine Institute (IVI) announced today that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ), which paves the way for public procurement of the vaccine by UN organizations and gives a boost to the global TCV supply.

23 Feb 2024

Sugar coatings on immunoglobulin G directly related to cardiovascular disease risk

When people hear about predicting heart disease, most will think of cholesterol levels. While cholesterol is a major contributor to heart disease, a recent study from Brigham and Women's Hospital, a founding member of Mass General Brigham, found that a glycan biomarker of IgG is also an important predictor for cardiovascular diseases (CVD).

23 Feb 2024

Natural killer cells lead the charge in cancer treatment innovation

Review synthesizes research on NK cells' role in cancer immunity and their potential in therapeutics through bioengineering, immune checkpoint inhibitors, and cell engagers, highlighting ongoing preclinical and clinical trials.

22 Feb 2024

Females' immune system edges out males but at a cost of higher autoimmune risk

A review article highlights how two X chromosomes in females influence immune system composition and function, leading to faster infection clearance and stronger vaccination responses but also a higher risk of autoimmune diseases.

22 Feb 2024

Elevated IFN-γ levels linked to long COVID, study finds

Researchers find elevated IFN-γ levels in long COVID patients, with symptom improvement correlating with decreased IFN-γ, suggesting it as a potential biomarker and target for therapeutic intervention.

22 Feb 2024

New immunotherapy target activin receptor 1C shows promise against cancer

Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients' immune systems fight back against cancer, according to a study by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

22 Feb 2024

Scripps Research scientists develop an antibody that blocks lethal snake toxins

Scripps Research scientists have developed an antibody that can block the effects of lethal toxins in the venoms of a wide variety of snakes found throughout Africa, Asia and Australia.

21 Feb 2024

ESMO Congress 2024: Shaping the future of anticancer therapies

The ESMO Targeted Anticancer Therapies Congress 2024 is the annual multi-stakeholder meeting that focuses on the development of novel anticancer therapies and how this can transform the current knowledge and impact clinical care.

21 Feb 2024

MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space

Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making advanced therapies more accessible to patients.

From MIP Discovery 20 Feb 2024

Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells

In a step forward for breast cancer treatment, researchers at Tohoku University have developed a novel monoclonal antibody which specifically targets a certain type of breast cancer cell.

19 Feb 2024

Wastewater clues could revolutionize Alzheimer's detection

Review explores the potential of wastewater-based epidemiology (WBE) for diagnosing Alzheimer's disease (AD) through biomarkers in biofluids, offering a non-invasive, cost-effective approach to early detection and large-scale monitoring.

18 Feb 2024

New study pinpoints key markers for Long COVID diagnosis

Study identifies elevated serologic responses and memory CD8+ T cell clonal expansion as key markers of Long COVID, offering insights into its pathology and potential diagnostic approaches.

18 Feb 2024

FDA approves omalizumab for food allergy reactions based on NIH research

Today's Food and Drug Administration approval of a supplemental biologics license for the monoclonal antibody omalizumab (Xolair) highlights the vital role of the National Institutes of Health-supported research that underpins the FDA decision.

16 Feb 2024

Study suggests patients with severe long COVID present with variable symptoms, do not cluster in relation to organs affected or immunological states

A new preprint reports significantly associated findings that may help predict severe long COVID and understand what causes it.

16 Feb 2024

Maternal mRNA COVID-19 vaccination shields infants for six months

Women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with strong protection against symptomatic COVID-19 infection for at least six months after birth, according to a study from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

15 Feb 2024

Antibody News and Research

Further Reading

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

Omalizumab shows promise in preventing food allergy reactions in children, study finds

Global health boost as new vaccine SKYTyphoid gains WHO prequalification

Sugar coatings on immunoglobulin G directly related to cardiovascular disease risk

Natural killer cells lead the charge in cancer treatment innovation

Females' immune system edges out males but at a cost of higher autoimmune risk

Elevated IFN-γ levels linked to long COVID, study finds

New immunotherapy target activin receptor 1C shows promise against cancer

Scripps Research scientists develop an antibody that blocks lethal snake toxins

ESMO Congress 2024: Shaping the future of anticancer therapies

MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space

Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells

Wastewater clues could revolutionize Alzheimer's detection

New study pinpoints key markers for Long COVID diagnosis

FDA approves omalizumab for food allergy reactions based on NIH research

Study suggests patients with severe long COVID present with variable symptoms, do not cluster in relation to organs affected or immunological states

Maternal mRNA COVID-19 vaccination shields infants for six months

Chula researchers develop wireless hepatitis B test kit for rapid diagnosis

Researchers discover new mechanism of action between the nutrient adaptation of intestinal stem cells and aging

Higher prepandemic physical activity levels associated with lower odds of developing and being hospitalized for COVID-19

Immunology eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News